PORTLAND, Ore., Oct. 13, 2017 /PRNewswire/ -- Otoharmonics continues to expand its sales leadership team with the hire of Joel Ellis, Senior Vice President of Sales. Fulfilling the latest step in Otoharmonics' growth strategy, Joel joins the team with over 20 years of experience in healthcare.
"With the Levo System's reputation as the new gold standard in tinnitus care, it's only fitting to bring an executive-level sales professional of Joel's caliber," said Michael Baker, President and CEO of Otoharmonics. "With Joel on board, the company is well positioned to broaden our reach within North America, UK and rest of world."
Joel has over two decades of experience in the healthcare field as a sales manager and senior executive, including experience in the hearing healthcare field where he served as National Sales Manager and VP of Managed Care for Beltone Electronics. Additionally, Joel functioned as Senior VP of Sales for AHAA (American Hearing Aid Associates), the forerunner for "buying groups" in the otolaryngology and audiology vertical.
"I'm excited to be a part of such a fabulous team," added Joel Ellis, Senior Vice President of Sales. "From day one at Otoharmonics I've been impressed with the willingness of people throughout the organization to support each other towards the common goal of bringing life-changing therapy to tinnitus patients."
Utilizing an FDA-cleared evidence-based approach, the Levo System offers a patented method to provide personalized sound therapy while sleeping. A soon to be released randomized study by the National Center for Rehabilitative Auditory Research team led by James Henry, Ph.D. at the VA Portland Health Care System demonstrated improved clinical outcomes for tinnitus patients using the Levo System.
To learn more about the Levo System visit http://otoharmonics.com.
About Otoharmonics Corporation
Otoharmonics Corporation is a privately held company with headquarters in Portland, Oregon USA. An international team of world-class neuroscientists, clinicians, business professionals and patients, Otoharmonics has developed the patented Levo System for the management of tinnitus symptoms. With a personal approach and a deep understanding of the impact tinnitus can have, Levo is designed to be user-friendly and capable of delivering custom sound therapy based on the specific needs of the individual.
Otoharmonics and Levo are registered trademarks of Otoharmonics Corporation.
View original content with multimedia:http://www.prnewswire.com/news-releases/otoharmonics-appoints-senior-vice-president-of-sales-300536447.html